Position in NTRA
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,171
+$572 QoQ
Shares Held
8
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#801
of 844 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Kilter Group LLC holds $218,310 across 17 Diagnostics & Research names. NTRA ranks #14 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVTY |
Revvity, Inc.
|
838 | $93,235 | |
| 2 | MEDP |
Medpace Holdings, Inc.
|
58 | $30,716 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
49 | $24,566 | |
| 4 | DHR |
Danaher Corp /De/
|
89 | $16,952 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
54 | $10,433 | |
| 6 | A |
Agilent Technologies, Inc.
|
54 | $7,172 | |
| 7 | DGX |
Quest Diagnostics Inc
|
27 | $5,722 | |
| 8 | VCYT |
Veracyte, Inc.
|
94 | $5,520 |
All Filings in NTRA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,171 | 8 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,599 | 8 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,832 | 8 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,287 | 8 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $1,351 | 8 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||